
Central Garden & Pet Company
NASDAQ•CENTA
CEO: Mr. William E. Brown
セクター: Consumer Defensive
業種: Packaged Foods
上場日: 2007-02-06
Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and containment, grooming products, waste management, and training pads; supplies for aquatics, small animals, reptiles, and pet birds, including toys, cages and habitats, bedding, and food and supplements; products for equine and livestock; animal and household health and insect control products; aquariums and terrariums, including fixtures and stands, water conditioners and supplements, water pumps and filters, and lighting systems and accessories; and live fish and small animals, as well as outdoor cushions. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, K&H Pet Products, Kaytee, Nylabone, and Zilla brands. Its Garden segment offers lawn and garden supplies products that include grass seed; vegetable; flower and herb packet seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the Amdro, Ferry-Morse, Pennington, and Sevin brands. The company sells its products to independent distributors, big-box retailers, national and regional retail chains, e-commerce and online retailers, grocery stores, nurseries, and mass merchants. Central Garden & Pet Company was founded in 1955 and is headquartered in Walnut Creek, California.
連絡先情報
時価総額
$2.12B
PER (TTM)
15.0
11.5
配当利回り
--
52週高値
$37.35
52週安値
$25.97
52週レンジ
順位31Top 21.6%
5.0
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 5 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025
財務ダッシュボード
Q1 2026 データ
売上高
$617.37M+0.00%
直近4四半期の推移
EPS
$0.11+0.00%
直近4四半期の推移
フリーCF
-$81.03M+0.00%
直近4四半期の推移
2026 Q1 決算ハイライト
主なハイライト
Gross Margin Improvement Noted Gross margin increased 110 basis points to 30.9% driven by productivity gains from Cost and Simplicity agenda across segments.
Net Sales Decline Reported Consolidated net sales decreased 6.0% to $617.4M, primarily due to shipment timing and portfolio optimization actions in both segments.
Strategic Animal Health Acquisition Acquired U.S. assets of Champion USA LLC for approximately $57M cash, strengthening position in fast-growing animal health segment.
Operating Income Fell Sharply Operating income declined 40.9% to $16.5M compared to prior year, reflecting lower sales volume and increased SG&A expenses.
リスク要因
Macroeconomic Uncertainty Persists Risks include economic uncertainty, potential recession, inflationary pressure, and impacts from tariffs or a potential trade war.
Litigation Judgment Under Appeal Company faces $7.2M judgment from Nite Glow litigation; management believes it will prevail on appeal despite inherent litigation uncertainty.
Garden Segment Seasonality Risk Garden business is highly seasonal; 64% of segment sales occurred in Q2/Q3, making Q1 results not indicative of full year performance.
Restructuring Charges Incurred Incurred $7.7M in Q1 FY2026 charges related to network optimization, including $7.2M in the Garden segment facility closures.
見通し
Liquidity Sufficient for Twelve Months Anticipate cash from operations and $600M Credit Facility adequacy to meet working capital and capital spending needs for next 12 months.
Fiscal 2026 Capital Investment Planned Anticipate approximately $50M in capital expenditures for fiscal 2026, focused on IT platform implementation and equipment upgrades.
Continued Growth Strategy Evaluation Management plans to continue evaluating potential acquisition candidates as part of growth strategy, potentially requiring external capital.
Debt Levels Remain Stable Total debt outstanding was $1,192.2M as of December 27, 2025, consistent with prior period levels, with all covenants met.
同業比較
売上高 (TTM)
ANDE$11.60B
FLO$5.26B
$4.91B
粗利益率 (最新四半期)
79.7%
59.2%
COUR54.2%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| TPB | $2.51B | 45.9 | 22.0% | 41.3% |
| ANDE | $2.36B | 32.0 | 5.6% | 23.5% |
| FLO | $2.19B | 26.1 | 6.0% | 55.7% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-9.5%
成長鈍化
4四半期純利益CAGR
-52.5%
収益性の低下
キャッシュフロー安定性
50%
キャッシュフローに注意が必要
深度リサーチ
次回決算:2026年5月5日
EPS:-
|売上高:-
財務レポート
財務データ
全年度
Form 10-Q - Q1 2026
会計期末: 2025年12月27日|提出日: 2026年2月5日|売上高: $617.37M+0.0%|EPS: $0.11+0.0%予想を下回るForm 10-K - FY 2025
会計期末: 2025年9月27日|提出日: 2025年11月26日|売上高: $3.13B-2.2%|EPS: $2.58+57.3%予想を上回るForm 10-Q - Q3 2025
会計期末: 2025年6月28日|提出日: 2025年8月7日|売上高: $960.91M-3.6%|EPS: $1.53+26.4%予想通りForm 10-Q - Q2 2025
会計期末: 2025年3月29日|提出日: 2025年5月8日|売上高: $833.54M-7.4%|EPS: $0.99+5.3%予想通りForm 10-Q - Q1 2025
会計期末: 2024年12月28日|提出日: 2025年2月6日|売上高: $656.44M+3.5%|EPS: $0.22+2582.9%予想を上回るForm 10-K - FY 2024
会計期末: 2024年9月28日|提出日: 2024年11月27日|売上高: $3.20B-3.3%|EPS: $1.64-30.2%予想を上回るForm 10-Q - Q3 2024
会計期末: 2024年6月29日|提出日: 2024年8月8日|売上高: $996.35M-2.6%|EPS: $1.21-23.4%予想通りForm 10-Q - Q2 2024
会計期末: 2024年3月30日|提出日: 2024年5月9日|売上高: $900.09M-1.0%|EPS: $0.94+28.8%予想を上回る